|
1
|
Bray F, Ren JS, Masuyer E and Ferlay J:
Global estimates of cancer prevalence for 27 sites in the adult
population in 2008. Int J Cancer. 132:1133–1145. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dijkstra MG, Snijders PJ, Arbyn M,
Rijkaart DC, Berkhof J and Meijer CJ: Cervical cancer screening: On
the way to a shift from cytology to full molecular screening. Ann
Oncol. 25:927–935. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Snijders PJ, Steenbergen RD, Heideman DA
and Meijer CJ: HPV-mediated cervical carcinogenesis: Concepts and
clinical implications. J Pathol. 208:152–164. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Burd EM: Human papillomavirus and cervical
cancer. Clin Microbiol Rev. 16:1–17. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ostör AG: Natural history of cervical
intraepithelial neoplasia: A critical review. Int J Gynecol Pathol.
12:186–192. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Daniel FI, Cherubini K, Yurgel LS, de
Figueiredo MA and Salum FG: The role of epigenetic transcription
repression and DNA methyltransferases in cancer. Cancer.
117:677–687. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bestor TH: The DNA methyltransferases of
mammals. Hum Mol Genet. 9:2395–2402. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Esteller M: Epigenetics in cancer. N Engl
J Med. 358:1148–1159. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Feinberg AP and Tycko B: The history of
cancer epigenetics. Nat Rev Cancer. 4:143–153. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cohen Y, Singer G, Lavie O, Dong SM,
Beller U and Sidransky D: The RASSF1A tumor suppressor gene is
commonly inactivated in adenocarcinoma of the uterine cervix. Clin
Cancer Res. 9:2981–2984. 2003.PubMed/NCBI
|
|
11
|
Feng Q, Balasubramanian A, Hawes SE, Toure
P, Sow PS, Dem A, Dembele B, Critchlow CW, Xi L, Lu H, et al:
Detection of hypermethylated genes in women with and without
cervical neoplasia. J Natl Cancer Inst. 97:273–282. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kang S, Kim HS, Seo SS, Park SY, Sidransky
D and Dong SM: Inverse correlation between RASSF1A
hypermethylation, KRAS and BRAF mutations in cervical
adenocarcinoma. Gynecol Oncol. 105:662–666. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wisman GB, Nijhuis ER, Hoque MO,
Reesink-Peters N, Koning AJ, Volders HH, Buikema HJ, Boezen HM,
Hollema H, Schuuring E, et al: Assessment of gene promoter
hypermethylation for detection of cervical neoplasia. Int J Cancer.
119:1908–1914. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wentzensen N, Sherman ME, Schiffman M and
Wang SS: Utility of methylation markers in cervical cancer early
detection: Appraisal of the state-of-the-science. Gynecol Oncol.
112:293–299. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tsai HT, Tsai YM, Yang SF, Wu KY, Chuang
HY, Wu TN, Ho CK, Lin CC, Kuo YS and Wu MT: Lifetime cigarette
smoke and second-hand smoke and cervical intraepithelial neoplasm-a
community-based case-control study. Gynecol Oncol. 105:181–188.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jo H, Kang S, Kim JW, Kang GH, Park NH,
Song YS, Park SY, Kang SB and Lee HP: Hypermethylation of the COX-2
gene is a potential prognostic marker for cervical cancer. J Obstet
Gynaecol Res. 33:236–241. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kang GH, Lee S, Lee HJ and Hwang KS:
Aberrant CpG island hypermethylation of multiple genes in prostate
cancer and prostatic intraepithelial neoplasia. J Pathol.
202:233–240. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Narayan G, Arias-Pulido H, Koul S, Vargas
H, Zhang FF, Villella J, Schneider A, Terry MB, Mansukhani M and
Murty VV: Frequent promoter methylation of CDH1, DAPK, RARB and
HIC1 genes in carcinoma of cervix uteri: Its relationship to
clinical outcome. Mol Cancer. 2:242003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Germain P, Chambon P, Eichele G, Evans RM,
Lazar MA, Leid M, de Lera AR, Lotan R, Mangelsdorf DJ and
Gronemeyer H: International union of pharmacology. LX. retinoic
acid receptors. Pharmacol Rev. 58:712–725. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Alvarez S, Germain P, Alvarez R,
Rodriguez-Barrios F, Gronemeyer H and de Lera AR: Structure,
function and modulation of retinoic acid receptor beta, a tumor
suppressor. Int J Biochem Cell Biol. 39:1406–1415. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Z: The role of COX-2 in oral cancer
development and chemoprevention/treatment of oral cancer by
selective COX-2 inhibitors. Curr Pharm Des. 11:1771–1777. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Warner DR, Smith SC, Smolenkova IA, Pisano
MM and Greene RM: Inhibition of p300 histone acetyltransferase
activity in palate mesenchyme cells attenuates Wnt signaling via
aberrant E-cadherin expression. Exp Cell Res. 342:32–38. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Widschwendter A, Ivarsson L, Blassnig A,
Müller HM, Fiegl H, Wiedemair A, Müller-Holzner E, Goebel G, Marth
C and Widschwendter M: CDH1 and CDH13 methylation in serum is an
independent prognostic marker in cervical cancer patients. Int J
Cancer. 109:163–166. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen CL, Liu SS, Ip SM, Wong LC, Ng TY and
Ngan HY: E-cadherin expression is silenced by DNA methylation in
cervical cancer cell lines and tumours. Eur J Cancer. 39:517–523.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dong SM, Kim HS, Rha SH and Sidransky D:
Promoter hypermethylation of multiple genes in carcinoma of the
uterine cervix. Clin Cancer Res. 7:1982–1986. 2001.PubMed/NCBI
|
|
27
|
Herman JG, Merlo A, Mao L, Lapidus RG,
Issa JP, Davidson NE, Sidransky D and Baylin SB: Inactivation of
the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA
methylation in all common human cancers. Cancer Res. 55:4525–4530.
1995.PubMed/NCBI
|
|
28
|
Serrano M: The tumor suppressor protein
p16INK4a. Exp Cell Res. 237:7–13. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wong YF, Chung TK, Cheung TH, Nobori T, Yu
AL, Yu J, Batova A, Lai KW and Chang AM: Methylation of p16INK4A in
primary gynecologic malignancy. Cancer Lett. 136:231–235. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yamamoto A, Kumakura S, Uchida M, Barrett
JC and Tsutsui T: Immortalization of normal human embryonic
fibroblasts by introduction of either the human papillomavirus type
16 E6 or E7 gene alone. Int J Cancer. 106:301–309. 2003. View Article : Google Scholar : PubMed/NCBI
|
